Atai Life Sciences NV 8-K filings

atai Life Sciences reports first quarter 2024 financial results, a leadership transition with co-founder Florian Brand stepping down as CEO by year-end, and provides updates on clinical trials.

atai Life Sciences announced its fourth quarter and full year 2023 financial results, highlighting positive clinical trial data and strategic investments.

atai Life Sciences has appointed Anne Johnson as its new Chief Financial Officer, succeeding Stephen Bardin, who will transition into an advisory role.

atai Life Sciences has acquired an additional 11,153,246 shares of Beckley Psytech for $10 million, increasing its total ownership to 35.47%.